Biomedical subjects

Marla R Hersh

Publications and source records attributed to Marla R Hersh.

4 recordsLinked to original sources

PubMed2006

High-performance wavelet compression for mammography: localization response operating characteristic evaluation.

PURPOSE: To evaluate the accuracy of a visually lossless, image-adaptive, wavelet-based compression method for achievement of high compression rates at mammography. MATERIALS AND METHODS: The study was approved by the institutional review board of the University of South Florida as a research study with existing medical records and was exempt from individual patient consent requirements. Patient identifiers were obliterated from all images. The study was HIPAA compliant. An algorithm based on scale-specific quantization of biorthogonal wavelet coefficients was developed for the compression of digitized mammograms with high spatial and dynamic resolution. The method was applied to 500 normal and abnormal mammograms from 278 patients who were 32-85 years old, 85 of whom had biopsy-proved cancer. Film images were digitized with a charge-coupled device-based digitizer. The original and compressed reconstructed images were evaluated in a localization response operating characteristic experiment involving three radiologists with 2-10 years of experience in reading mammograms. RESULTS: Compression rates in the range of 14:1 to 2051:1 were achieved, and the rates were dependent on the degree of parenchymal density and the type of breast structure. Ranges of the area under the receiver operating characteristic curve were 0.70-0.83 and 0.72-0.86 for original and compressed reconstructed mammograms, respectively. Ranges of the area under the localization response operating characteristic curve were 0.39-0.65 and 0.43-0.71 for original and compressed reconstructed mammograms, respectively. The localization accuracy increased an average of 6% (0.04 of 0.67) with the compressed mammograms. Localization performance differences were statistically significant with P = .05 and favored interpretation with the wavelet-compressed reconstructed images. CONCLUSION: The tested wavelet-based compression method proved to be an accurate approach for digitized mammography and yielded visually lossless high-rate compression and improved tumor localization.

Adult↗

PubMed2005

Imaging gastrointestinal stromal tumors.

BACKGROUND: Because of the recent reclassification of mesenchymal tumors, which was based on a better understanding of the genetics and immunophenotype of gastrointestinal stromal tumors (GISTs), only a limited number of studies have described the radiologic appearance of GISTs. METHODS: This study reviews the imaging characteristics of GISTs, with an emphasis on differentiating benign and malignant tumors using positron emission tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI). We reviewed the data from 53 cases of GISTs treated at our institute. The imaging studies from these cases, which were recorded at our institute from January 1998 through June 2003, included PET, CT, and MRI. RESULTS: Of the 53 GIST cases, stomach and small bowel tumors accounted for 80% of the tumors. Malignant lesions were larger and more heterogeneous, had ulcerations, and were PET positive. Peritoneal and liver metastases were most common. CONCLUSIONS: PET, CT, and MRI appear to be useful in differentiating nonmetastasizing from malignant GISTs.

Adult↗

PubMed2004

Improved interpretation of digitized mammography with wavelet processing: a localization response operating characteristic study.

OBJECTIVE: Our objective was the implementation and evaluation of a novel enhancement technique for improved interpretation of high-resolution digitized mammograms from computer monitors. MATERIALS AND METHODS: A wavelet algorithm was designed to attenuate the image spectral characteristics responsible for the long-range image correlation that often interferes with digital display. The algorithm was evaluated with a localization response operating characteristic (LROC) experiment with 500 negative, benign, and cancer cases with masses and calcification clusters. Three observers reviewed the original and wavelet-enhanced images on a 5-Mpixel monitor using a custom-made workstation user interface. RESULTS: Performance indexes were estimated for four different case combinations, each observer, and each interpretation mode. Wavelet enhancement improved the performance of all observers in all case combinations. Detection accuracy ranged from 0.678 to 0.827 for the unprocessed original data and 0.709-0.871 for the enhanced cases. Localization accuracy ranged from 0.547 to 0.785 for the original images and 0.568-0.847 for the enhanced cases, yielding increases of 5-15%. The difference between enhanced and original performances was statistically significant at the 0.10 level and in a few combinations at the 0.05 level. CONCLUSION: Soft-copy digitized mammography could replace standard film mammography under appropriate display parameters and conditions. The optimization of the soft-copy quality is expected to require more advanced processing techniques than standard gray-scale adjustments. Wavelet-based algorithms, such as the one proposed here, offer better soft-copy quality than the originals and a better starting point for additional manual gray-scale adjustments or automated postprocessing.

Algorithms↗

PubMedDate not supplied

Newer imaging modalities to assess tumor in the prostate.

BACKGROUND: Several advances in the imaging of prostate cancer have been made in recent years. Diagnostic staging has become increasingly complex and confusing as newer technologies have developed more rapidly than research has been able to confirm or refute the accuracy of these technologies. By the time research has been performed, the technology used for a study has often become outdated and newer and more sophisticated imaging has become available. METHODS: We reviewed the literature on local and nodal staging of prostate cancer, as well as the role of magnetic resonance imaging (MRI), magnetic resonance spectroscopic imaging (MRSI), dynamic contrast-enhanced MRI, positron emission tomography (PET), endorectal power Doppler, lymphotropic MRI contrast agents, and future possibilities such as diffusion MRI. This review is not systematic, but rather focused on these imaging modalities. RESULTS: Advances in MRI, ultrasound, and lymphotropic contrast agents have improved our ability to differentiate between T2 and T3 prostate tumors. PET imaging has proven less successful at staging prostate cancer. A literature review suggests patients with moderate risk of extracapsular extension benefit most from endorectal MRI evaluation. Spectroscopy, dynamic imaging, and lymphotropic contrast agents are expected to continue to improve sensitivity and specificity of staging of prostate cancer. Power Doppler evaluation with endorectal ultrasound has proved useful for evaluation during endorectal biopsy for identifying hypervascular tumors for directed biopsy. Diffusion-weighted MRI remains untested clinically and represents a future direction for research. CONCLUSIONS: Future studies using these new techniques are needed to demonstrate changes in outcomes in large patient populations.

Contrast Media↗